During this period, FDA has stated it will not take enforcement action against compounders who continue to make tirzepatide products.) While it is highly likely that FDA will not address either Novo Nordisks or Eli Lilly and Companys submission until after the Proposed Rule is finalized, it is important that any entities compounding these drugs are aware that further changes to the rules may impact their ability to compound such drugs in the near future
The various treatments for gastroparesis can severely impact ones quality of life and incur large medical bills
Chronic hyperglycemia leads to accumulation of advanced glycation end products (AGEs) in bone collagen, reducing bone material properties and increasing brittleness
We built MeAgain to turn those tasks into a simple game with a friendly capybara, shot reminders, side-effect logs, and a Journey Card to share with your clinician
With so many individuals now being prescribed GLP-1s for weight loss, shortages of the drugs have become chronic
Trials have shown that users can rapidly pile pounds back on once they stop taking the fat-fighting drug and it can trigger a variety of nasty side effects
